{"filing":{"accession_number":"0001193125-26-269650","cik":"0001974640","ticker":"APGE","company_name":"Apogee Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"apge-20260609.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/apge-20260609.htm"},"events":[{"id":10350,"run_id":9077,"accession_number":"0001193125-26-269650","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K Item 5.07 discloses the final voting results from Apogee Therapeutics' June 9, 2026 Annual Meeting of Stockholders, including three proposals: election of Class III directors (Mark C. McKenna, Jennifer Fox, and William Jones, Jr.), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies for each proposal are the core disclosure required under Item 5.07.","company_name":"Apogee Therapeutics, Inc.","ticker":"APGE","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":6643,"accession_number":"0001193125-26-269650","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from Apogee Therapeutics' June 9, 2026 Annual Meeting of Stockholders, including three proposals: election of Class III directors (Mark C. McKenna, Jennifer Fox, and William Jones, Jr.), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies for each proposal are the core disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:04:35.369479+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6643,"accession_number":"0001193125-26-269650","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from Apogee Therapeutics' June 9, 2026 Annual Meeting of Stockholders, including three proposals: election of Class III directors (Mark C. McKenna, Jennifer Fox, and William Jones, Jr.), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies for each proposal are the core disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:04:35.369479+00:00","company_name":"Apogee Therapeutics, Inc.","ticker":"APGE","filing_date":"2026-06-12"}]}